Human Bcl-2 ELISA Kit (Colorimetric)
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-91188
Key Product Details
Sample Type & Volume Required Per Well
Cell lysate, serum, plasma (20 uL)
Sensitivity
0.5 ng/mL
Assay Range
0.50 - 32.0 ng/mL
Product Specifications
Assay Type
Sandwich ELISA
Kit Type
ELISA Kit (Colorimetric)
Reactivity
Human
Description
The human Bcl-2 ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human Bcl-2.
Precision
Intra-Assay Precision (Precision within an assay) CV% < 8.60%
Inter-Assay Precision (Precision between assays) CV% < 12%
Recovery for Human Bcl-2 ELISA Kit (Colorimetric)
Recovery
71%
Scientific Data Images for Human Bcl-2 ELISA Kit (Colorimetric)
ELISA: Human Bcl-2 ELISA Kit (Colorimetric) [NBP1-91188]
ELISA: Bcl-2 ELISA Kit [NBP1-91188] - Standard curveKit Contents for Human Bcl-2 ELISA Kit (Colorimetric)
- Adhesive Films
- Aluminium pouch(es) with a Microwell Plate coated with monoclonal antibody to human Bcl-2
- Assay Buffer Concentrate 20x (PBS with 1% Tween 20 and 10% BSA)
- Biotin-Conjugate anti-human Bcl-2 monoclonal antibody
- Human Bcl-2 Standard lyophilized, 64 ng/mL upon reconstitution
- Lysis Buffer 10x
- Sample Diluent
- Stop Solution (1M Phosphoric acid)
- Streptavidin-HRP
- Substrate Solution (tetramethyl-benzidine)
- Wash Buffer Concentrate 20x (PBS with 1% Tween 20)
Preparation and Storage
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Storage of components varies. See protocol for specific instructions.
Background: Bcl-2
Long Name
B Cell Lymphoma/Leukemia 2
Alternate Names
Bcl2
Gene Symbol
BCL2
Additional Bcl-2 Products
Product Documents for Human Bcl-2 ELISA Kit (Colorimetric)
Product Specific Notices for Human Bcl-2 ELISA Kit (Colorimetric)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. ELISA Kits are guaranteed for 6 months from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...